ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech to webcast conference call discussing first quarter 2005 financial results VANCOUVER, April 27 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), will webcast its conference call discussing financial results for the first quarter ended March 30th, 2005 on Wednesday, May 4th, 2005 at 2:00 PM PST (5:00 PM EST). The webcast will be available to all interested parties through Angiotech's website (http://www.angiotech.com/) under Investor Relations or by dialing toll-free in North America to (800-510-9661) (International callers please dial (617) 614-3452) and entering Passcode 98019456. To ensure a timely connection to the webcast it is recommended that users register approximately 15 minutes before the conference call. A recording of the call will be available until May 11th, 2005 by dialing toll-free in North America (888) 286-8010 (International at (617) 801-6888) and entering Passcode 20027692. A press release will be issued prior to the conference call. The conference call will be hosted by William Hunter, President and Chief Executive Officer, and David Hall, Chief Financial Officer. The webcast will be available for seven days on the Angiotech website. Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for challenging disease states and advance surgical outcomes. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/. CONTACTS: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors) (604) 221-7676 ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts) (604) 221-7676 ext 6996 Eric Starkman, Starkman & Associates (Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors), (604) 221-7676 ext 6933; Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts), (604) 221-7676 ext 6996; Eric Starkman, Starkman & Associates (Media), (212) 252-8545 ext 12

Copyright